Trial · NCT00900146
Participant flow40
How many started, completed or left each group, period by period.
1 to 20 of 40
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Dose Finding: Period II (4 Months) | STARTED | Canakinumab 5 mg + Metformin | 93 | |
| Dose Finding: Period II (4 Months) | STARTED | Canakinumab 15 mg + Metformin | 95 | |
| Dose Finding: Period II (4 Months) | STARTED | Canakinumab 50 mg + Metformin | 92 | |
| Dose Finding: Period II (4 Months) | STARTED | Canakinumab 150 mg + Metformin | 92 | |
| Dose Finding: Period II (4 Months) | STARTED | Placebo + Metformin | 179 | |
| Dose Finding: Period II (4 Months) | Full Analysis Set (FAS)/Safety | Canakinumab 5 mg + Metformin | 93 | |
| Dose Finding: Period II (4 Months) | Full Analysis Set (FAS)/Safety | Canakinumab 15 mg + Metformin | 95 | |
| Dose Finding: Period II (4 Months) | Full Analysis Set (FAS)/Safety | Canakinumab 50 mg + Metformin | 92 | |
| Dose Finding: Period II (4 Months) | Full Analysis Set (FAS)/Safety | Canakinumab 150 mg + Metformin | 92 | |
| Dose Finding: Period II (4 Months) | Full Analysis Set (FAS)/Safety | Placebo + Metformin | 179 | |
| Dose Finding: Period II (4 Months) | COMPLETED | Canakinumab 5 mg + Metformin | 88 | |
| Dose Finding: Period II (4 Months) | COMPLETED | Canakinumab 15 mg + Metformin | 93 | |
| Dose Finding: Period II (4 Months) | COMPLETED | Canakinumab 50 mg + Metformin | 87 | |
| Dose Finding: Period II (4 Months) | COMPLETED | Canakinumab 150 mg + Metformin | 90 | |
| Dose Finding: Period II (4 Months) | COMPLETED | Placebo + Metformin | 167 | |
| Dose Finding: Period II (4 Months) | NOT COMPLETED | Canakinumab 5 mg + Metformin | 5 | |
| Dose Finding: Period II (4 Months) | NOT COMPLETED | Canakinumab 15 mg + Metformin | 2 | |
| Dose Finding: Period II (4 Months) | NOT COMPLETED | Canakinumab 50 mg + Metformin | 5 | |
| Dose Finding: Period II (4 Months) | NOT COMPLETED | Canakinumab 150 mg + Metformin | 2 | |
| Dose Finding: Period II (4 Months) | NOT COMPLETED | Placebo + Metformin | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00900146/flow